• Development of Orally Absorbable Cisplatin Prodrugs Enclosed in Liposomes and Their Application as a Treatment for Lung Cancer

  • Jeong Man An# , Kushal Chakraborty*,# , Muhammad Anugrah Pratama*,# , Nipa Banik**, Mi Kwon Son***, and Yong-kyu Lee**, ***,†

  • Department of Bioengineering, College of Engineering, Hanyang University, Seoul 04763, Korea
    *Department of IT and Energy Convergence (BK21 FOUR), Korea National University of Transportation, Chungju 27470, Korea
    **Department of Chemical and Biological Engineering, Graduate School, Korea National University of Transportation, Chungju 27469, Korea
    ***4D Convergence Technology Institute, Korea National University of Transportation, Chungju 7469, Korea

  • 리포좀에 봉입된 경구 흡수성 시스플라틴 전구약물의 개발 및 폐암 치료제로의 응용

  • 안정만# · 쿠샬차크라보르티*,# · 무함마드아누그라프라타마*,# · 니파바니크** · 손미권*** · 이용규**, ***,†

  • 한양대학교 공과대학 생명공학과, *한국교통대학교 교통에너지융합학과, **한국교통대학교 화공생물공학과, ***한국교통대학교 4D 융합기술연구소

  • Reproduction, stored in a retrieval system, or transmitted in any form of any part of this publication is permitted only by written permission from the Polymer Society of Korea.

References
  • 1. Rebecca, L. Siegel, Kimberly D Miller, Nikita Sandeep Wage, A Hmedin Jemal; Cancer Statistics, 2023. CA Cancer J. Clin. 2023, 73, 17-48.
  •  
  • 2. Woodman, C.; Vundu, G.; George, A.; Wilson, C. M. Applications and Strategies in Nanodiagnosis and Nanotherapy in Lung Cancer. Semin. Cancer Biol. 2021, 69, 349-364.
  •  
  • 3. Kobir, M. E.; Ahmed, A.; Roni, M. A. H.; Chakma, U.; Amin, M. R.; Chandro, A.; Kumer, A. Anti-lung Cancer Drug Discovery Approaches by Polysaccharides: An in Silico Study, Quantum Calculation and Molecular Dynamics Study. J. Biomol. Struct. Dyn. 2023, 41, 6616-6632.
  •  
  • 4. Imran Vhora, Nirav Khatri, Jagruti Desai, Hetal Paresh Thakkar; Caprylate-conjugated Cisplatin for the Development of Novel Liposomal Formulation. AAPS PharmSciTech. 2014, 15, 845-857.
  •  
  • 5. Akimaru, K.; Auzenne, E.; Akimaru, Y.; Leroux, M. E.; Hayman, A. C.; Utsumi, T. Formulation and Antitumor Efficacy of Liposomal Caprylated-TNF-SAM2. Cytokines Mol. Ther. 1995, 3, 197-210.
  •  
  • 6. Utsumi, T.; Hung, M. C.; Klostergaard, J. Preparation and Characterization of Liposomal-lipophilic Tumor Necrosis Factor. Cancer Res. 1991, 51, 3362-3366.
  •  
  • 7. Cafaggi, S.; Russo, E.; Stefani, R.; Leardi, R.; Caviglioli, G.; Parodi, B. Preparation and Evaluation of Nanoparticles Made of Chitosan or N-trimethyl Chitosan and a Cisplatin-alginate Complex. J. Control. Release. 2007, 121, 110-123.
  •  
  • 8. Yan, X.; Gemeinhart, R. A. Cisplatin Delivery From Poly(acrylic acid-co-methyl methacrylate) Microparticles. J. Control. Release. 2005, 106, 198-208.
  •  
  • 9. Chandrababu Rejeeth, Tapas C. Nag, Soundarapandian Kannan; Cisplatin-functionalized Silica Nanoparticles for Cancer Chemotherapy. Cancer Nano 2013, 4, 127-136.
  •  
  • 10. Hamman, J. H.; Demana, P. H.; Olivier, E. I. Targeting Receptors, Transporters and Site of Absorption to Improve Oral Drug Delivery. Drug. Target. Insights. 2007, 2, 71-81.
  •  
  • 11. Khatun, Z.; Nurunnabi, M.; Reeck, G. R.; Cho, K. J.; Lee, Y.-K. Oral Delivery of Taurocholic Acid Linked Heparin–docetaxel Conjugates for Cancer Therapy. J. Controll. Release, 2013, 170, 74-82.
  •  
  • 12. Kim, S. K.; Huh, J.; Kim, S. K.; Byun, Y.; Lee, D. Y.; Moon, H. T. Physicochemical Conjugation with Deoxycholic Acid and Dimethylsulfoxide for Heparin Oral Delivery. Bioconjug. Chem. 2011, 22, 1451-1458.
  •  
  • 13. Khatun, Z.; Nurunnabi, M.; Reeck, G. R.; Cho, K. J.; Lee, Y.-K. Oral Delivery of Taurocholic Acid Linked Heparin-docetxel Conjugates for Cancer Therapy. J. Control. Release, 2013, 170, 74-82.
  •  
  • 14. Andersson, A.; Hedenmalm, H.; Elfsson, B.; Ehrsson, H. Determination of the Acid Dissociation Constant for Cis-diammineaquachloroplatinum (II)ion. A Hydrolysis Product of Cisplatin. J. Pharm. Sci. 1994, 83, 859-862.
  •  
  • 15. Ramos, Y.; Hernandez, C.; Fernandez, L. A.; Bataller, M.; Veliz, E.; Small, R. Optimization of a HPLC Procedure for Simultaneous Determination of Cisplatin and the Complex Cis, Cis, Trans-diamminedichlorodihydroxoplatinum (IV) in Aqueous Solutions. Quim. Nova, 2011, 34, 1450-1454.
  •  
  • 16. Anilanmert, B.; Yalcin, G.; Arioz, F.; Dolen, E. The Spectrophotometric Determination of Cisplatin in Urine, Using o-Phenylenediamine as Derivatizing Agent. Anal Lett. 2001, 34, 113-123.
  •  
  • 17. Munawara, I.; Shi, Y.; Koneru, B.; Patel, A.; Dang, M. H.; Di Pasqua, A. J.; Balkus Jr, K. J. Nitric Oxide-and Cisplatin-releasing Silica Nanoparticles for Use Against Non-small Cell Lung Cancer. J. Inorg. Biochem. 2015, 153, 23-31.
  •  
  • 18. Werner, M. E.; Copp, J. A.; Karve, S.; Cummings, N. D.; Sukumar, R.; Li, C. Folate-targeted polymeric Nanoparticle Formulation of Docetaxel is An Effective Molecularly Targeted Radiosensitizer with Efficacy Dependent on the Timing of Radiotherapy. ACS Nano 2011, 5, 8990-8998.
  •  
  • 19. Yan, X.; Gemeinhart, R. A. Cisplatin Delivery From Poly(acrylic acid-co-methyl methacrylate) Microparticles. J. Control. Release. 2005, 106, 198-208.
  •  
  • 20. Ebrahimi Shahmabadi, H.; Akbarzadeh, A.; Mokhtari, M. J.; Mortazavi, M.; Ghasemi, S.; Mohammadi, H.; Dou, S. K. B. In vitro Evaluation of the Effects of Acetone, on the Potency of Cisplatin: is it a Good Candidate for Cisplatin Carrier Preparation. Biotechnol. Pharm Res. 2012, 3, 137-140.
  •  
  • 21. Ebrahimi Shahmabadi, H.; Movahedi, F.; Koohi Moftakhari Esfahani, M.; Alavi, S. E.; Eslamifar, A.; Mohammadi Anaraki, G.; Akbarzadeh, A. Efficacy of Cisplatin Loaded Polybutyl Cyanoacrylatenanoparticles on the Glioblastoma. Tumor Biol. 2014, 35, 4799-4806.
  •  
  • 22. Tomas Zimmermann, Jerzy Leszczynski, Jaroslav V Burda. Activation of the Cisplatin and Transplatin Complexes in Solution with Constant pH and Concentration of Chloride Anions; Quantum Chemical Study. J. Molecul. Modeling 2011, 17, 2385-2393.
  •  
  • 23. Kastantin, M.; Ananthanarayanan, B.; Karmali, P.; Ruoslahti, E.; Tirrell, M. Effect of the Lipid Chain Melting Transition on the Stability of DSPE-PEG(2000) Micelles. Langmuir 2009, 25, 7279-7286.
  •  
  • 24. Zhong, J.; Huang, H.-L.; Li, J.; Qian, F.-C.; Li, L.-Q.; Niu, P.-P.; Dai, L.-C. Development of Hybrid-type Modified Chitosan Derivative Nanoparticles for the Intracellular Delivery of Midkine-siRNA in Hepatocellular Carcinoma Cells. Hepatobil. Pancreat. Dis. Int. 2015, 14, 82-89.
  •  
  • 25. Liu, M.; Zhang, X.; Yang, B.; Deng, F.; Ji, J.; Yang, Y.; Huang, Z.; Zhang, X.; Wei, Y. Luminescence Tunable Fluorescent Organic Nanoparticles from Polyethyleneimine and Maltose: Facile Preparation and Bioimaging Applications. RSC Adv. 2014, 4, 22294-22298.
  •  
  • 26. Sun, Y.; Peng, Y.; Chen, Y.; Shukla, A. J. Application of Artificial Neural Networks in the Design of Controlled Release Drug Delivery Systems. Adv. Drug Deliv. Rev. 2003, 55, 1201-1215.
  •  
  • Polymer(Korea) 폴리머
  • Frequency : Bimonthly(odd)
    ISSN 2234-8077(Online)
    Abbr. Polym. Korea
  • 2024 Impact Factor : 0.6
  • Indexed in SCIE

This Article

  • 2025; 49(5): 570-578

    Published online Sep 25, 2025

  • 10.7317/pk.2025.49.5.570
  • Received on Jan 30, 2025
  • Revised on Apr 21, 2025
  • Accepted on Apr 21, 2025

Correspondence to

  • Yong-kyu Lee

  • **Department of Chemical and Biological Engineering, Graduate School, Korea National University of Transportation, Chungju 27469, Korea
    ***4D Convergence Technology Institute, Korea National University of Transportation, Chungju 7469, Korea

  • E-mail: leeyk@ut.ac.kr